OPY vs TLRY · P/E 13, rev $1.43B vs rev $821.3M
Oppenheimer Holdings Inc (OPY) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the OPY and TLRY stock pages for the full models.
Not investment advice.